At a glance
- Originator Chiesi
- Class Antiplatelets; Heart failure therapies; Vasodilators
- Mechanism of Action Endopeptidase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure
Most Recent Events
- 28 Feb 1995 Discontinued-Preclinical for Heart failure in Italy (Unknown route)